Borosil Scientific Ltd is Rated Strong Sell

Understanding the Current Rating

The Strong Sell rating assigned to Borosil Scientific Ltd indicates a cautious stance for investors, suggesting that the stock is expected to underperform relative to the broader market and its peers. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment appeal and risk profile.

Quality Assessment

As of 02 February 2026, Borosil Scientific’s quality grade is classified as average. The company’s return on equity (ROE) stands at a modest 4.53%, reflecting limited profitability generated from shareholders’ funds. This level of ROE suggests that the company is not efficiently converting equity capital into earnings, which is a concern for long-term value creation. Additionally, the management efficiency appears suboptimal, with the company showing weak operational leverage and limited growth in core profitability metrics.

Valuation Considerations

The stock is currently deemed expensive based on valuation metrics. With a price-to-book (P/B) ratio of approximately 2.4, Borosil Scientific trades at a premium relative to its book value despite its subdued profitability. This elevated valuation is not supported by commensurate earnings growth or return metrics, which raises questions about the stock’s price sustainability. Investors should be wary of paying a premium for a company with limited financial momentum and below-par returns.

Financial Trend Analysis

The financial trend for Borosil Scientific is negative as of the current date. Over the past five years, net sales have grown at an annualised rate of 9.80%, while operating profit growth has been a mere 2.86%, indicating sluggish expansion in core earnings. The latest quarterly results for September 2025 reveal a significant decline in profit before tax (PBT) excluding other income, which fell by 55.8% to ₹2.98 crores compared to the previous four-quarter average. Furthermore, the profit after tax (PAT) for the nine months ended September 2025 contracted by 39.40% to ₹14.01 crores. Notably, non-operating income constitutes 41.91% of PBT, highlighting reliance on income sources outside the company’s primary business operations.

Technical Outlook

The technical grade for Borosil Scientific is currently bearish. The stock has underperformed significantly over multiple time frames. As of 02 February 2026, the stock’s returns include a 1-day decline of 1.18%, a 1-month drop of 9.04%, and a 3-month fall of 20.45%. Over six months, the stock has lost 31.68%, and year-to-date it is down 9.45%. The one-year return stands at a negative 33.23%, reflecting sustained downward momentum. This performance trails the broader BSE500 index and indicates weak investor sentiment and selling pressure.

Additional Insights on Shareholding and Market Position

Despite being a small-cap company in the industrial products sector, Borosil Scientific has minimal interest from domestic mutual funds, which hold only 0.04% of the company’s equity. Given that mutual funds typically conduct thorough research and favour companies with strong fundamentals and growth prospects, this low stake may signal concerns about the company’s valuation or business outlook. The stock’s underperformance relative to benchmarks over the last one to three years further underscores the challenges faced by the company in delivering shareholder value.

What This Rating Means for Investors

The Strong Sell rating suggests that investors should exercise caution and consider the risks associated with holding Borosil Scientific Ltd shares at this time. The combination of average quality, expensive valuation, negative financial trends, and bearish technical indicators points to a stock that may continue to face downward pressure. Investors seeking capital preservation or growth may find more attractive opportunities elsewhere, particularly in companies with stronger profitability, reasonable valuations, and positive momentum.

Summary of Key Metrics as of 02 February 2026

• Return on Equity (ROE): 4.53%
• Price to Book Value (P/B): 2.4
• Net Sales Growth (5-year CAGR): 9.80%
• Operating Profit Growth (5-year CAGR): 2.86%
• Profit Before Tax (excluding other income) Q3 Sep 2025: ₹2.98 crores (-55.8%)
• Profit After Tax (9 months ended Sep 2025): ₹14.01 crores (-39.40%)
• Non-operating Income as % of PBT: 41.91%
• Stock Returns: 1Y -33.23%, 6M -31.68%, 3M -20.45%, 1M -9.04%, 1W +2.45%, 1D -1.18%

Investor Considerations and Outlook

Given the current rating and underlying fundamentals, investors should carefully evaluate their exposure to Borosil Scientific Ltd. The company’s modest profitability and slow growth, combined with an expensive valuation and weak technical signals, suggest limited upside potential in the near term. The reliance on non-operating income to bolster profits further complicates the earnings quality assessment. For those holding the stock, monitoring quarterly results and any shifts in operational efficiency or market sentiment will be critical.

Potential investors may prefer to wait for clearer signs of financial improvement or a more attractive valuation before initiating positions. The stock’s recent performance relative to the BSE500 index and its sector peers indicates that it has struggled to keep pace with broader market gains, reinforcing the cautious stance implied by the current rating.

Conclusion

Borosil Scientific Ltd’s Strong Sell rating by MarketsMOJO, last updated on 21 January 2026, reflects a comprehensive assessment of the company’s current challenges. As of 02 February 2026, the stock exhibits average quality, expensive valuation, negative financial trends, and bearish technicals, all of which contribute to a cautious investment outlook. Investors should consider these factors carefully when making portfolio decisions involving this stock.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →